Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2012-02-17 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-PIERRE-DES-NIDS (53370), Mayenne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DES AVALOIRS : revenue, balance sheet and financial ratios
SARL PHARMACIE DES AVALOIRS is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-PIERRE-DES-NIDS (53370),
this company of category PME
shows in 2025 a net income positive of 91 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DES AVALOIRS (SIREN 750071813)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
91 491 €
93 553 €
94 712 €
72 786 €
75 170 €
58 889 €
66 212 €
56 146 €
55 902 €
63 541 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SARL PHARMACIE DES AVALOIRS generates positive net income of 91 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 64 k€ -> 91 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
91 491 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 89%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
89.193%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.161%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DES AVALOIRS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
265.268
224.2
205.727
186.226
168.997
147.645
132.358
110.844
95.662
89.193
Financial autonomy
23.615
26.827
28.536
30.049
31.311
33.006
35.434
38.399
43.413
46.161
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
89.192025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of SARL PHARMACIE DES AVALOIRS (89.19) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.16%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of SARL PHARMACIE DES AVALOIRS (46.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 145.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
145.567
Liquidity indicators evolution SARL PHARMACIE DES AVALOIRS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
163.793
164.501
161.431
153.69
140.874
129.981
128.34
117.433
121.091
145.567
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
145.572025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average+10 pts over 3 years
In 2025, the liquidity ratio of SARL PHARMACIE DES AVALOIRS (145.57) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SARL PHARMACIE DES AVALOIRS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SARL PHARMACIE DES AVALOIRS is estimated at
1 453 345 €
(range 986 247€ - 2 280 499€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
986k€1453k€2280k€
1 453 345 €Range: 986 247€ - 2 280 499€
NAF 5 année 2025
Valuation method used
Net Income Multiple
91 491 €
×
15.9x
=1 453 345 €
Range: 986 247€ - 2 280 499€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DES AVALOIRS with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DES AVALOIRS
What is the revenue of SARL PHARMACIE DES AVALOIRS ?
The revenue of SARL PHARMACIE DES AVALOIRS is not publicly disclosed (confidential accounts filed with INPI).
Is SARL PHARMACIE DES AVALOIRS profitable?
Yes, SARL PHARMACIE DES AVALOIRS generated a net profit of 91 k€ in 2025.
Where is the headquarters of SARL PHARMACIE DES AVALOIRS ?
The headquarters of SARL PHARMACIE DES AVALOIRS is located in SAINT-PIERRE-DES-NIDS (53370), in the department Mayenne.
Where to find the tax return of SARL PHARMACIE DES AVALOIRS ?
The tax return of SARL PHARMACIE DES AVALOIRS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DES AVALOIRS operate?
SARL PHARMACIE DES AVALOIRS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart